Epilepsy surgery trends in the United States, 1990―2008

To examine national time trends of resective surgery for the treatment of medically refractory epilepsy before and after Class I evidence demonstrating its efficacy and subsequent practice guidelines recommending early surgical evaluation. We performed a population-based cohort study with time trend...

Full description

Saved in:
Bibliographic Details
Published in:Neurology Vol. 78; no. 16; pp. 1200 - 1206
Main Authors: ENGLOT, D. J, OUYANG, D, GARCIA, P. A, BARBARO, N. M, CHANG, E. F
Format: Journal Article
Language:English
Published: Hagerstown, MD Lippincott Williams & Wilkins 17-04-2012
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract To examine national time trends of resective surgery for the treatment of medically refractory epilepsy before and after Class I evidence demonstrating its efficacy and subsequent practice guidelines recommending early surgical evaluation. We performed a population-based cohort study with time trends of patients admitted to US hospitals for medically refractory focal epilepsy between 1990 and 2008 who did or did not undergo lobectomy, as reported in the Nationwide Inpatient Sample. Weighted data revealed 112,026 hospitalizations for medically refractory focal epilepsy and 6,653 resective surgeries (lobectomies and partial lobectomies) from 1990 to 2008. A trend of increasing hospitalizations over time was not accompanied by an increase in surgeries, producing an overall trend of decreasing surgery rates (F = 13.6, p < 0.01). Factors associated with this trend included a decrease in epilepsy hospitalizations at the highest-volume epilepsy centers, and increased hospitalizations to lower-volume hospitals that were found to be less likely to perform surgery. White patients were more likely to have surgery than racial minorities (relative risk [RR], 1.13; 95% confidence interval [CI], 1.10-1.17), and privately insured individuals were more likely to receive lobectomy than those with Medicaid or Medicare (RR, 1.28; 95% CI, 1.25-1.30). Despite Class I evidence and subsequent practice guidelines, the utilization of lobectomy has not increased from 1990 to 2008. Surgery continues to be heavily underutilized as a treatment for epilepsy, with significant disparities by race and insurance coverage. Patients who are medically refractory after failing 2 antiepileptic medications should be referred to a comprehensive epilepsy center for surgical evaluation.
AbstractList OBJECTIVETo examine national time trends of resective surgery for the treatment of medically refractory epilepsy before and after Class I evidence demonstrating its efficacy and subsequent practice guidelines recommending early surgical evaluation. METHODSWe performed a population-based cohort study with time trends of patients admitted to US hospitals for medically refractory focal epilepsy between 1990 and 2008 who did or did not undergo lobectomy, as reported in the Nationwide Inpatient Sample. RESULTSWeighted data revealed 112,026 hospitalizations for medically refractory focal epilepsy and 6,653 resective surgeries (lobectomies and partial lobectomies) from 1990 to 2008. A trend of increasing hospitalizations over time was not accompanied by an increase in surgeries, producing an overall trend of decreasing surgery rates (F = 13.6, p < 0.01). Factors associated with this trend included a decrease in epilepsy hospitalizations at the highest-volume epilepsy centers, and increased hospitalizations to lower-volume hospitals that were found to be less likely to perform surgery. White patients were more likely to have surgery than racial minorities (relative risk [RR], 1.13; 95% confidence interval [CI], 1.10-1.17), and privately insured individuals were more likely to receive lobectomy than those with Medicaid or Medicare (RR, 1.28; 95% CI, 1.25-1.30). CONCLUSIONDespite Class I evidence and subsequent practice guidelines, the utilization of lobectomy has not increased from 1990 to 2008. Surgery continues to be heavily underutilized as a treatment for epilepsy, with significant disparities by race and insurance coverage. Patients who are medically refractory after failing 2 antiepileptic medications should be referred to a comprehensive epilepsy center for surgical evaluation.
Objective: To examine national time trends of resective surgery for the treatment of medically refractory epilepsy before and after Class I evidence demonstrating its efficacy and subsequent practice guidelines recommending early surgical evaluation. Methods: We performed a population-based cohort study with time trends of patients admitted to US hospitals for medically refractory focal epilepsy between 1990 and 2008 who did or did not undergo lobectomy, as reported in the Nationwide Inpatient Sample. Results: Weighted data revealed 112,026 hospitalizations for medically refractory focal epilepsy and 6,653 resective surgeries (lobectomies and partial lobectomies) from 1990 to 2008. A trend of increasing hospitalizations over time was not accompanied by an increase in surgeries, producing an overall trend of decreasing surgery rates (F = 13.6, p < 0.01). Factors associated with this trend included a decrease in epilepsy hospitalizations at the highest-volume epilepsy centers, and increased hospitalizations to lower-volume hospitals that were found to be less likely to perform surgery. White patients were more likely to have surgery than racial minorities (relative risk [RR], 1.13; 95% confidence interval [CI], 1.10-1.17), and privately insured individuals were more likely to receive lobectomy than those with Medicaid or Medicare (RR, 1.28; 95% CI, 1.25-1.30). Conclusion: Despite Class I evidence and subsequent practice guidelines, the utilization of lobectomy has not increased from 1990 to 2008. Surgery continues to be heavily underutilized as a treatment for epilepsy, with significant disparities by race and insurance coverage. Patients who are medically refractory after failing 2 antiepileptic medications should be referred to a comprehensive epilepsy center for surgical evaluation.
To examine national time trends of resective surgery for the treatment of medically refractory epilepsy before and after Class I evidence demonstrating its efficacy and subsequent practice guidelines recommending early surgical evaluation. We performed a population-based cohort study with time trends of patients admitted to US hospitals for medically refractory focal epilepsy between 1990 and 2008 who did or did not undergo lobectomy, as reported in the Nationwide Inpatient Sample. Weighted data revealed 112,026 hospitalizations for medically refractory focal epilepsy and 6,653 resective surgeries (lobectomies and partial lobectomies) from 1990 to 2008. A trend of increasing hospitalizations over time was not accompanied by an increase in surgeries, producing an overall trend of decreasing surgery rates (F = 13.6, p < 0.01). Factors associated with this trend included a decrease in epilepsy hospitalizations at the highest-volume epilepsy centers, and increased hospitalizations to lower-volume hospitals that were found to be less likely to perform surgery. White patients were more likely to have surgery than racial minorities (relative risk [RR], 1.13; 95% confidence interval [CI], 1.10-1.17), and privately insured individuals were more likely to receive lobectomy than those with Medicaid or Medicare (RR, 1.28; 95% CI, 1.25-1.30). Despite Class I evidence and subsequent practice guidelines, the utilization of lobectomy has not increased from 1990 to 2008. Surgery continues to be heavily underutilized as a treatment for epilepsy, with significant disparities by race and insurance coverage. Patients who are medically refractory after failing 2 antiepileptic medications should be referred to a comprehensive epilepsy center for surgical evaluation.
Author CHANG, E. F
OUYANG, D
GARCIA, P. A
ENGLOT, D. J
BARBARO, N. M
Author_xml – sequence: 1
  givenname: D. J
  surname: ENGLOT
  fullname: ENGLOT, D. J
  organization: UCSF Epilepsy Center, United States
– sequence: 2
  givenname: D
  surname: OUYANG
  fullname: OUYANG, D
  organization: UCSF Epilepsy Center, United States
– sequence: 3
  givenname: P. A
  surname: GARCIA
  fullname: GARCIA, P. A
  organization: Department of Neurology, University of California, San Francisco, United States
– sequence: 4
  givenname: N. M
  surname: BARBARO
  fullname: BARBARO, N. M
  organization: UCSF Epilepsy Center, United States
– sequence: 5
  givenname: E. F
  surname: CHANG
  fullname: CHANG, E. F
  organization: UCSF Epilepsy Center, United States
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=26425341$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/22442428$$D View this record in MEDLINE/PubMed
BookMark eNqNkc1u1DAUhS1URKeFN0AoGyQWTbk_dmJvkKqqBaQRLKCCneWxnTYo4wx2Bml2vAQvyJMQ1KH8rFjdxfnO0b33HImDNKYoxGOEUySk5x_eLE9hBciRUZOC0EZ3TyxQUVM3TB8PxAKAdM261YfiqJRPALPYmgfikEhKkqQXwlxs-iFuyq4q23wd866ackyhVH2qpptYXaV-iqF6N7kplpMKjYHvX78RgH4o7nduKPHRfh6Lq8uL9-ev6uXbl6_Pz5a1ly1ONQbsEBSzcYE9OqWb2LFfkeMQlGQTGr2ad6ROI2vtlXdKtb41XTDBaM_H4sVt7ma7WsfgY5qyG-wm92uXd3Z0vf1bSf2NvR6_WGaSTDAHPNsH5PHzNpbJrvvi4zC4FMdtsQgoEXSD9B8okJLzG_WMylvU57GUHLu7jRDsz4LsXJD9t6DZ9uTPa-5MvxqZgad7wBXvhi675Pvym2skKZbIPwAq45sQ
CODEN NEURAI
CitedBy_id crossref_primary_10_1111_epi_17923
crossref_primary_10_1016_j_yebeh_2018_12_023
crossref_primary_10_1007_s10072_020_05016_x
crossref_primary_10_1002_epi4_12919
crossref_primary_10_1016_j_clineuro_2017_05_001
crossref_primary_10_5698_1535_7511_16_4_232
crossref_primary_10_1007_s00381_013_2168_7
crossref_primary_10_1111_epi_12912
crossref_primary_10_1016_j_yebeh_2014_12_027
crossref_primary_10_1016_j_seizure_2022_11_012
crossref_primary_10_1097_WCO_0000000000000067
crossref_primary_10_1016_j_yebeh_2024_109707
crossref_primary_10_1016_j_eplepsyres_2016_05_001
crossref_primary_10_1016_j_eplepsyres_2018_02_012
crossref_primary_10_1016_j_nic_2020_02_002
crossref_primary_10_1016_j_yebeh_2016_12_033
crossref_primary_10_1016_j_wneu_2018_10_043
crossref_primary_10_1016_j_yebeh_2021_107910
crossref_primary_10_1016_j_clineuro_2017_10_038
crossref_primary_10_1016_j_praneu_2014_10_005
crossref_primary_10_1016_j_yebeh_2013_06_020
crossref_primary_10_1016_j_eplepsyres_2015_07_007
crossref_primary_10_1007_s10143_014_0527_9
crossref_primary_10_23736_S0390_5616_18_04448_X
crossref_primary_10_2176_nmc_st_2021_0230
crossref_primary_10_2214_AJR_22_27925
crossref_primary_10_1109_TBME_2018_2797919
crossref_primary_10_1111_ene_12322
crossref_primary_10_1186_s41983_020_00168_1
crossref_primary_10_1016_j_eplepsyres_2018_10_006
crossref_primary_10_1177_2329048X211012544
crossref_primary_10_1016_j_nec_2014_11_015
crossref_primary_10_3171_2013_5_PEDS12526
crossref_primary_10_1227_NEU_0000000000001799
crossref_primary_10_1111_epi_14627
crossref_primary_10_1016_j_spen_2021_100916
crossref_primary_10_25259_SNI_824_2021
crossref_primary_10_1016_j_clinph_2014_04_017
crossref_primary_10_1016_j_nec_2015_08_004
crossref_primary_10_1016_j_yebeh_2021_108227
crossref_primary_10_3171_2019_4_JNS183235
crossref_primary_10_1212_WNL_0b013e3182a55fb9
crossref_primary_10_1016_S1474_4422_15_70011_6
crossref_primary_10_1111_epi_12791
crossref_primary_10_1177_1179573520935031
crossref_primary_10_1111_ane_13393
crossref_primary_10_1016_j_yebeh_2017_03_017
crossref_primary_10_3171_2019_9_JNS191769
crossref_primary_10_1111_epi_13766
crossref_primary_10_1016_S1474_4422_14_70156_5
crossref_primary_10_1016_j_ncl_2020_09_010
crossref_primary_10_1016_j_jocn_2016_12_002
crossref_primary_10_1111_epi_14045
crossref_primary_10_1192_bjpo_bp_115_002345
crossref_primary_10_1002_epi4_12789
crossref_primary_10_1227_neu_0000000000002811
crossref_primary_10_1227_neu_0000000000001961
crossref_primary_10_1016_j_clineuro_2024_108151
crossref_primary_10_1212_WNL_0000000000012514
crossref_primary_10_1016_j_yebeh_2017_08_010
crossref_primary_10_1016_j_aorn_2017_09_003
crossref_primary_10_1080_14737175_2019_1650642
crossref_primary_10_1016_j_yebeh_2021_107837
crossref_primary_10_1016_j_wneu_2017_01_093
crossref_primary_10_1007_s00330_020_07645_4
crossref_primary_10_1016_j_seizure_2021_07_007
crossref_primary_10_3171_2021_7_JNS21123
crossref_primary_10_1002_epi4_12541
crossref_primary_10_1212_01_CON_0000431397_61970_2b
crossref_primary_10_3389_fneur_2014_00244
crossref_primary_10_1111_epi_16572
crossref_primary_10_1136_jnnp_2012_304038
crossref_primary_10_1016_j_yebeh_2018_01_030
crossref_primary_10_46563_2686_8997_2021_2_1_29_37
crossref_primary_10_1016_j_clineuro_2013_09_035
crossref_primary_10_3171_2020_6_JNS20732
crossref_primary_10_1016_S0140_6736_18_32596_0
crossref_primary_10_3171_2013_5_PEDS1336
crossref_primary_10_1007_s10143_016_0725_8
crossref_primary_10_1212_WNL_0000000000005776
crossref_primary_10_1002_ana_24635
crossref_primary_10_1002_epi4_12099
crossref_primary_10_1016_j_jns_2019_06_026
crossref_primary_10_1080_14737175_2020_1713100
crossref_primary_10_1002_epi4_12650
crossref_primary_10_1111_ane_13008
crossref_primary_10_1007_s00415_017_8394_2
crossref_primary_10_1016_j_jocn_2014_12_002
crossref_primary_10_1212_WNL_0b013e318250d86b
crossref_primary_10_1111_epi_16320
crossref_primary_10_1136_jnnp_2017_316833
crossref_primary_10_1016_j_neuropharm_2019_107762
crossref_primary_10_1016_j_ncl_2022_03_010
crossref_primary_10_1016_j_ncl_2022_03_012
crossref_primary_10_1111_epi_13058
crossref_primary_10_1016_j_seizure_2020_05_013
crossref_primary_10_1016_j_yebeh_2021_107853
crossref_primary_10_1016_j_seizure_2021_02_002
crossref_primary_10_1212_WNL_0000000000000750
crossref_primary_10_1038_nrneurol_2012_181
crossref_primary_10_1002_epi4_12874
crossref_primary_10_1016_j_wneu_2017_05_004
crossref_primary_10_1007_s40265_015_0395_9
crossref_primary_10_1016_j_seizure_2018_11_007
crossref_primary_10_1007_s00381_017_3639_z
crossref_primary_10_3171_2018_12_PEDS18350
crossref_primary_10_1016_j_wneu_2015_05_009
crossref_primary_10_1111_epi_16436
crossref_primary_10_1212_WNL_0000000000013130
crossref_primary_10_1212_WNL_0000000000000740
crossref_primary_10_1007_s10309_023_00571_7
crossref_primary_10_1016_j_eplepsyres_2021_106725
crossref_primary_10_1093_neuros_nyz556
crossref_primary_10_1212_WNL_0000000000002249
crossref_primary_10_1111_epi_16423
crossref_primary_10_1177_0883073820966935
crossref_primary_10_1016_j_seizure_2015_01_005
crossref_primary_10_1111_epi_12988
crossref_primary_10_1227_NEU_0000000000000286
crossref_primary_10_1016_j_ultrasmedbio_2020_01_008
crossref_primary_10_1001_jamaneurol_2024_0551
crossref_primary_10_1016_j_ncl_2021_04_001
crossref_primary_10_1016_S0140_6736_14_60456_6
crossref_primary_10_1016_j_yebeh_2015_04_033
crossref_primary_10_1016_S1474_4422_17_30429_5
crossref_primary_10_3171_2014_8_GKS141608
crossref_primary_10_1227_ons_0000000000000230
crossref_primary_10_1227_NEU_0000000000001165
crossref_primary_10_1111_dmcn_13292
crossref_primary_10_1111_epi_12974
crossref_primary_10_1016_j_clinph_2015_05_009
crossref_primary_10_1016_j_seizure_2013_02_015
crossref_primary_10_1111_epi_16414
crossref_primary_10_1097_WCO_0b013e32835ef345
crossref_primary_10_1016_j_eplepsyres_2012_07_016
crossref_primary_10_1016_j_eplepsyres_2015_05_007
crossref_primary_10_1212_CPJ_0000000000000490
crossref_primary_10_1007_s00381_024_06319_6
crossref_primary_10_1111_epi_12979
crossref_primary_10_5698_1535_7597_13_5_198
crossref_primary_10_1016_j_yebeh_2014_06_013
crossref_primary_10_1212_CPJ_0000000000000011
crossref_primary_10_1212_01_wnl_0000419803_22062_59
crossref_primary_10_1016_j_seizure_2019_05_004
crossref_primary_10_1007_s11910_012_0287_2
crossref_primary_10_1002_epi4_12965
crossref_primary_10_1016_j_yebeh_2022_108925
crossref_primary_10_1111_epi_18030
crossref_primary_10_1016_j_yebeh_2022_108923
crossref_primary_10_1016_S1474_4422_14_70325_4
crossref_primary_10_5698_1535_7597_16_1_21
crossref_primary_10_3390_brainsci8020022
crossref_primary_10_3171_2018_1_FOCUS17683
crossref_primary_10_1111_epi_16637
crossref_primary_10_1016_j_yebeh_2017_05_026
crossref_primary_10_1111_epi_13489
crossref_primary_10_3171_2016_12_JNS162096
crossref_primary_10_1016_j_wneu_2016_12_074
crossref_primary_10_1111_epi_12719
crossref_primary_10_1177_1535759720941061
crossref_primary_10_1111_epi_17172
crossref_primary_10_3171_CASE22210
crossref_primary_10_1111_epi_12957
crossref_primary_10_1212_01_CON_0000431398_69594_97
crossref_primary_10_3171_2014_1_JNS131694
crossref_primary_10_1111_ene_12358
crossref_primary_10_5694_mja17_00951
crossref_primary_10_1212_CPJ_0000000000000628
crossref_primary_10_1212_WNL_0000000000005021
crossref_primary_10_1212_CPJ_0000000000000625
crossref_primary_10_1212_WNL_0000000000200569
crossref_primary_10_1016_j_yebeh_2012_05_017
crossref_primary_10_1016_j_ebr_2022_100527
crossref_primary_10_1111_epi_12148
crossref_primary_10_1111_epi_13116
crossref_primary_10_1002_hbm_22628
crossref_primary_10_1016_j_neuron_2015_03_037
crossref_primary_10_1016_j_yebeh_2021_108529
crossref_primary_10_1212_WNL_0000000000003407
crossref_primary_10_1111_ane_13418
crossref_primary_10_1212_CPJ_0000000000200259
crossref_primary_10_1016_j_yebeh_2021_108403
crossref_primary_10_3171_2022_1_JNS212613
crossref_primary_10_1016_j_eplepsyres_2020_106473
crossref_primary_10_7887_jcns_23_627
crossref_primary_10_1016_j_wneu_2018_09_079
crossref_primary_10_1016_j_clineuro_2020_106416
crossref_primary_10_1055_s_0042_1760105
crossref_primary_10_1016_j_eplepsyres_2019_106252
crossref_primary_10_12688_f1000research_17714_1
crossref_primary_10_3171_2020_1_FOCUS19935
crossref_primary_10_1016_j_neurom_2023_11_007
crossref_primary_10_1016_j_yebeh_2017_12_041
crossref_primary_10_1016_j_wneu_2018_11_170
crossref_primary_10_1016_S1474_4422_16_30127_2
crossref_primary_10_1002_ana_25205
crossref_primary_10_1016_j_eplepsyres_2016_01_009
crossref_primary_10_1016_j_pcl_2021_04_016
crossref_primary_10_1016_j_nec_2017_06_001
crossref_primary_10_3171_2012_9_JNS12776
crossref_primary_10_1111_epi_17499
crossref_primary_10_2176_nmc_ra_2014_0414
crossref_primary_10_1016_j_eplepsyres_2015_09_012
crossref_primary_10_1016_j_clineuro_2018_01_017
crossref_primary_10_7759_cureus_45996
crossref_primary_10_1212_CPJ_0000000000000048
crossref_primary_10_1039_C9AY02582K
Cites_doi 10.1212/WNL.0b013e3181eee510
10.1097/SLA.0b013e3181a77cb3
10.1016/j.eplepsyres.2010.11.005
10.1016/S0079-6123(09)17711-7
10.1056/NEJM200002033420503
10.1111/j.1528-1167.2006.00569.x
10.1093/brain/awl364
10.1001/jama.2008.771
10.1111/j.1528-1167.2008.01898.x
10.1001/archneurol.2010.86
10.1001/jama.2008.756
10.1097/WCO.0b013e32834479a7
10.3171/2011.7.JNS11977
10.1227/01.NEU.0000065129.25359.EE
10.1212/01.WNL.0000055086.35806.2D
10.3171/jns.2000.92.1.0024
10.1111/j.1528-1167.2010.02648.x
10.1111/j.1528-1167.2009.02237.x
10.1016/j.yebeh.2006.05.011
10.1684/epd.2010.0303
10.3171/2008.12.JNS081112
10.1212/WNL.0b013e3181eee457
10.1111/j.1528-1167.2006.00702.x
10.1056/NEJM200108023450510
10.1016/S1474-4422(08)70109-1
10.1001/jama.2010.885
10.1111/j.1528-1167.2007.01136.x
10.1046/j.1528-1157.42.s6.1.x
10.1017/S1092852900008488
10.1056/NEJM200108023450501
10.1002/ana.22142
10.1001/archneurol.2011.7
10.1111/j.1528-1167.2009.02282.x
ContentType Journal Article
Copyright 2015 INIST-CNRS
Copyright © 2012 by AAN Enterprises, Inc. 2012 AAN Enterprises, Inc.
Copyright_xml – notice: 2015 INIST-CNRS
– notice: Copyright © 2012 by AAN Enterprises, Inc. 2012 AAN Enterprises, Inc.
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
7TK
5PM
DOI 10.1212/WNL.0b013e318250d7ea
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
Neurosciences Abstracts
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
Neurosciences Abstracts
DatabaseTitleList MEDLINE - Academic
Neurosciences Abstracts
MEDLINE
Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1526-632X
EndPage 1206
ExternalDocumentID 10_1212_WNL_0b013e318250d7ea
22442428
26425341
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations United States
North America
America
GeographicLocations_xml – name: United States
GroupedDBID ---
-~X
.55
.GJ
.XZ
.Z2
01R
08R
0R~
123
1CY
1J1
1KJ
29N
2WC
354
3PY
4Q1
4Q2
4Q3
53G
5RE
5VS
6PF
77Y
A9M
AAAXR
AAGIX
AAHPQ
AAJCS
AAMOA
AAMTA
AAPBV
AAQKA
AAQQT
AARTV
AASOK
AASXQ
AAUGY
AAWTL
AAXQO
AAYEP
AAYOK
ABBLC
ABIVO
ABOCM
ACCJW
ACDDN
ACGFS
ACILI
ACOAL
ACWRI
ADGGA
ADNKB
AE6
AEBDS
AENEX
AFDTB
AFFNX
AFUWQ
AGINI
AHOMT
AHVBC
AIJEX
AKALU
AKULP
ALMA_UNASSIGNED_HOLDINGS
AMJPA
AMKUR
AMNEI
AOHHW
AWKKM
BOYCO
BQLVK
BYPQX
C45
CS3
DIWNM
DU5
E.X
EBS
EJD
EX3
F2K
F2L
F2M
F2N
F5P
FA8
FCALG
FW0
GQDEL
HZ~
H~9
IKYAY
IN~
IPNFZ
IQODW
J5H
JF7
KD2
KMI
L-C
L7B
N4W
N9A
NEJ
N~7
N~B
O9-
OAG
OAH
OBH
ODMTH
OHH
OHT
OHYEH
OJAPA
OL1
OLB
OLH
OLU
OLV
OLW
OLY
OLZ
OPX
OVD
OVDNE
OVIDH
OVLEI
OWU
OWV
OWW
OWX
OWY
OWZ
OXXIT
P2P
RHI
RIG
RLZ
RXW
SJN
TAE
TEORI
TWZ
UDS
V2I
VVN
W3M
WH7
WOQ
WOW
X7M
XJT
XOL
XSW
XXN
XYM
XYN
YBU
YCJ
YFH
YYP
ZA5
ZGI
ZKB
ZXP
~9M
AAIQE
AASCR
ABJNI
ABVCZ
ACLDA
ACXJB
AFEXH
AHQNM
AKWKN
CGR
CUY
CVF
ECM
EIF
ERAAH
NPM
AAYXX
CITATION
7X8
7TK
5PM
ID FETCH-LOGICAL-c471t-1d1f105339ad3c1a586ef3cb2a3dd5439d68b3872f81388c5ca557c79fd9d98c3
ISSN 0028-3878
IngestDate Tue Sep 17 21:22:46 EDT 2024
Fri Oct 25 05:05:15 EDT 2024
Fri Oct 25 11:41:46 EDT 2024
Thu Nov 21 21:14:09 EST 2024
Tue Oct 15 23:44:55 EDT 2024
Sun Oct 22 16:06:01 EDT 2023
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 16
Keywords Nervous system diseases
Surgery
Epilepsy
Central nervous system disease
Cerebral disorder
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c471t-1d1f105339ad3c1a586ef3cb2a3dd5439d68b3872f81388c5ca557c79fd9d98c3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
Study funding: Supported in part by the Clinical and Translational Science Institute at UCSF. Statistical support was provided by Dr. Cheng at the Clinical and Translational Science Institute Consultations Services at UCSF.
OpenAccessLink https://europepmc.org/articles/pmc3324320?pdf=render
PMID 22442428
PQID 1002540158
PQPubID 23479
PageCount 7
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3324320
proquest_miscellaneous_1014108612
proquest_miscellaneous_1002540158
crossref_primary_10_1212_WNL_0b013e318250d7ea
pubmed_primary_22442428
pascalfrancis_primary_26425341
PublicationCentury 2000
PublicationDate 2012-04-17
PublicationDateYYYYMMDD 2012-04-17
PublicationDate_xml – month: 04
  year: 2012
  text: 2012-04-17
  day: 17
PublicationDecade 2010
PublicationPlace Hagerstown, MD
PublicationPlace_xml – name: Hagerstown, MD
– name: United States
PublicationTitle Neurology
PublicationTitleAlternate Neurology
PublicationYear 2012
Publisher Lippincott Williams & Wilkins
Publisher_xml – name: Lippincott Williams & Wilkins
References 16839821 - Epilepsy Behav. 2006 Sep;9(2):243-64
21177075 - Epilepsy Res. 2011 Feb;93(2-3):115-9
11902321 - Epilepsia. 2001;42 Suppl 6:4-8
20733142 - Neurology. 2010 Aug 24;75(8):678-9
21838505 - J Neurosurg. 2011 Dec;115(6):1248-55
10616078 - J Neurosurg. 2000 Jan;92(1):24-30
11484695 - N Engl J Med. 2001 Aug 2;345(5):365-7
19702735 - Epilepsia. 2009 Sep;50 Suppl 8:57-62
17209228 - Brain. 2007 Feb;130(Pt 2):574-84
19575575 - J Neurosurg. 2010 Jan;112(1):168-85
19818900 - Prog Brain Res. 2009;177:147-70
20457957 - Arch Neurol. 2010 May;67(5):577-83
11484687 - N Engl J Med. 2001 Aug 2;345(5):311-8
17105474 - Epilepsia. 2006;47 Suppl 2:96-8
14758935 - J Neurosurg. 2004 Feb;100(2 Suppl Pediatrics):90-7
19561457 - Ann Surg. 2009 Jul;250(1):159-65
20733145 - Neurology. 2010 Aug 24;75(8):699-704
19732134 - Epilepsia. 2009 Oct;50(10):2285-95
14999168 - CNS Spectr. 2004 Feb;9(2):120-2, 126-32
16822241 - Epilepsia. 2006 Jun;47(6):952-9
12601090 - Neurology. 2003 Feb 25;60(4):538-47
22442432 - Neurology. 2012 Apr 17;78(16):1194-5
10660394 - N Engl J Med. 2000 Feb 3;342(5):314-9
12762870 - Neurosurgery. 2003 Jun;52(6):1251-61; discussion 1261-2
16397445 - Rev Neurol Dis. 2004 Winter;1(1):2-9
20606149 - JAMA. 2010 Jul 7;304(1):53-60
19050199 - JAMA. 2008 Dec 3;300(21):2548-50
21301338 - Curr Opin Neurol. 2011 Apr;24(2):159-64
19050193 - JAMA. 2008 Dec 3;300(21):2497-505
20976764 - Ann Neurol. 2010 Oct;68(4):424-34
20561026 - Epilepsia. 2010 Nov;51(11):2322-33
21320984 - Arch Neurol. 2011 Jun;68(6):725-9
19054413 - Epilepsia. 2009 May;50(5):1040-50
12088294 - Eff Clin Pract. 2002 May-Jun;5(3):143-51
17521343 - Epilepsia. 2007 Jul;48(7):1303-7
20211804 - Epileptic Disord. 2010 Mar;12(1):3-15
22987746 - Neurology. 2012 Sep 18;79(12):1302; author reply 1302
18485316 - Lancet Neurol. 2008 Jun;7(6):525-37
Engel J (e_1_3_7_10_2) 1993
Smith ER (e_1_3_7_34_2) 2004; 100
e_1_3_7_40_2
e_1_3_7_20_2
e_1_3_7_22_2
e_1_3_7_21_2
e_1_3_7_24_2
e_1_3_7_23_2
e_1_3_7_26_2
e_1_3_7_25_2
e_1_3_7_28_2
e_1_3_7_27_2
e_1_3_7_29_2
e_1_3_7_9_2
e_1_3_7_31_2
Steiner C (e_1_3_7_14_2) 2002; 5
e_1_3_7_30_2
e_1_3_7_33_2
e_1_3_7_11_2
e_1_3_7_32_2
e_1_3_7_12_2
e_1_3_7_35_2
e_1_3_7_13_2
e_1_3_7_37_2
e_1_3_7_15_2
e_1_3_7_36_2
e_1_3_7_16_2
e_1_3_7_39_2
e_1_3_7_17_2
e_1_3_7_38_2
e_1_3_7_18_2
Engel J (e_1_3_7_3_2) 1987
e_1_3_7_19_2
e_1_3_7_4_2
Devinsky O (e_1_3_7_2_2) 2004; 1
e_1_3_7_6_2
e_1_3_7_5_2
e_1_3_7_8_2
e_1_3_7_7_2
References_xml – ident: e_1_3_7_25_2
  doi: 10.1212/WNL.0b013e3181eee510
– ident: e_1_3_7_37_2
  doi: 10.1097/SLA.0b013e3181a77cb3
– ident: e_1_3_7_20_2
  doi: 10.1016/j.eplepsyres.2010.11.005
– ident: e_1_3_7_27_2
  doi: 10.1016/S0079-6123(09)17711-7
– ident: e_1_3_7_26_2
  doi: 10.1056/NEJM200002033420503
– ident: e_1_3_7_33_2
  doi: 10.1111/j.1528-1167.2006.00569.x
– ident: e_1_3_7_5_2
  doi: 10.1093/brain/awl364
– ident: e_1_3_7_11_2
  doi: 10.1001/jama.2008.771
– ident: e_1_3_7_40_2
  doi: 10.1111/j.1528-1167.2008.01898.x
– ident: e_1_3_7_15_2
  doi: 10.1001/archneurol.2010.86
– ident: e_1_3_7_6_2
  doi: 10.1001/jama.2008.756
– ident: e_1_3_7_19_2
  doi: 10.1097/WCO.0b013e32834479a7
– ident: e_1_3_7_22_2
  doi: 10.3171/2011.7.JNS11977
– ident: e_1_3_7_35_2
  doi: 10.1227/01.NEU.0000065129.25359.EE
– volume: 1
  start-page: 2
  year: 2004
  ident: e_1_3_7_2_2
  article-title: Diagnosis and treatment of temporal lobe epilepsy
  publication-title: Rev Neurol Dis
  contributor:
    fullname: Devinsky O
– ident: e_1_3_7_13_2
  doi: 10.1212/01.WNL.0000055086.35806.2D
– volume: 100
  start-page: 90
  year: 2004
  ident: e_1_3_7_34_2
  article-title: In-hospital mortality rates after ventriculoperitoneal shunt procedures in the United States, 1998 to 2000: relation to hospital and surgeon volume of care
  publication-title: J Neurosurg
  contributor:
    fullname: Smith ER
– ident: e_1_3_7_31_2
  doi: 10.3171/jns.2000.92.1.0024
– ident: e_1_3_7_32_2
  doi: 10.1111/j.1528-1167.2010.02648.x
– start-page: 553
  volume-title: Surgical Treatment of the Epilepsies
  year: 1987
  ident: e_1_3_7_3_2
  contributor:
    fullname: Engel J
– ident: e_1_3_7_7_2
  doi: 10.1111/j.1528-1167.2009.02237.x
– start-page: 23
  volume-title: Surgical Treatment of the Epilepsies
  year: 1993
  ident: e_1_3_7_10_2
  contributor:
    fullname: Engel J
– ident: e_1_3_7_38_2
  doi: 10.1016/j.yebeh.2006.05.011
– ident: e_1_3_7_18_2
  doi: 10.1684/epd.2010.0303
– ident: e_1_3_7_23_2
  doi: 10.3171/2008.12.JNS081112
– ident: e_1_3_7_24_2
– ident: e_1_3_7_8_2
  doi: 10.1212/WNL.0b013e3181eee457
– ident: e_1_3_7_28_2
  doi: 10.1111/j.1528-1167.2006.00702.x
– ident: e_1_3_7_9_2
  doi: 10.1056/NEJM200108023450510
– ident: e_1_3_7_4_2
  doi: 10.1016/S1474-4422(08)70109-1
– volume: 5
  start-page: 143
  year: 2002
  ident: e_1_3_7_14_2
  article-title: The healthcare cost and utilization project: an overview
  publication-title: Eff Clin Pract
  contributor:
    fullname: Steiner C
– ident: e_1_3_7_36_2
  doi: 10.1001/jama.2010.885
– ident: e_1_3_7_21_2
  doi: 10.1111/j.1528-1167.2007.01136.x
– ident: e_1_3_7_30_2
  doi: 10.1046/j.1528-1157.42.s6.1.x
– ident: e_1_3_7_29_2
  doi: 10.1017/S1092852900008488
– ident: e_1_3_7_12_2
  doi: 10.1056/NEJM200108023450501
– ident: e_1_3_7_17_2
  doi: 10.1002/ana.22142
– ident: e_1_3_7_16_2
  doi: 10.1001/archneurol.2011.7
– ident: e_1_3_7_39_2
  doi: 10.1111/j.1528-1167.2009.02282.x
SSID ssj0015279
Score 2.5437505
Snippet To examine national time trends of resective surgery for the treatment of medically refractory epilepsy before and after Class I evidence demonstrating its...
OBJECTIVETo examine national time trends of resective surgery for the treatment of medically refractory epilepsy before and after Class I evidence...
Objective: To examine national time trends of resective surgery for the treatment of medically refractory epilepsy before and after Class I evidence...
SourceID pubmedcentral
proquest
crossref
pubmed
pascalfrancis
SourceType Open Access Repository
Aggregation Database
Index Database
StartPage 1200
SubjectTerms Adult
Anterior Temporal Lobectomy - trends
Biological and medical sciences
Data processing
Drug Resistance
Epilepsy
Epilepsy - surgery
European Continental Ancestry Group - statistics & numerical data
Female
Guideline Adherence - trends
Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy
Hospitalization - trends
Hospitals
Humans
Insurance, Hospitalization - statistics & numerical data
Male
Medicaid - statistics & numerical data
Medical sciences
Medicare - statistics & numerical data
Minority Groups - statistics & numerical data
Nervous system (semeiology, syndromes)
Neurology
Practice Guidelines as Topic
Races
Risk assessment
Surgery
United States
Title Epilepsy surgery trends in the United States, 1990―2008
URI https://www.ncbi.nlm.nih.gov/pubmed/22442428
https://search.proquest.com/docview/1002540158
https://search.proquest.com/docview/1014108612
https://pubmed.ncbi.nlm.nih.gov/PMC3324320
Volume 78
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZokRASQrxZHpWRuIFhbcexc0Q0pUJLitSt6C1ybEf0kl2R7qH_nnHsPLasUDlwiTbexNmdLx5_M54ZI_TWZdzZlFpCDdMksdqQSsxrOAVzpJqnWaV9cvLxqSzO1WGe5OPGf2Pbf0Ua2gBrnzn7D2gPnUIDfAbM4Qiow_FGuOdrGOfr9updGxKefSh5jHr9g2N6-VKYKPxfU1Oa2pXsmPrbfbbvqtPXh-NC0snmKnqbh7DhL35roo6Pfp96Sf2aRueTLaL3NfoZfMBGQkJa5QcXdSNLScq73c8H5SnV9CWZqkIaSpD20yqcpjtVNsydINMfxWL0yQIts9JNpqh-Wb44KY_OFotymZ8v99BtBsrF67bTr8WwciSgMaZIQs8fd_W7RUHurXULo6EO25jssjOuh8tO-MfyAbofDQf8KSD-EN1yzSN051sMjXiMZA88jsDjADy-aDAAjwPwOAD_Hg-wP0FnR_ny8zGJu2IQA0TiklBLa-ozqDNtuaFaqNTV3FRMc2sF8EubqooryWpFuVJGGC2ENDKrbWYzZfhTtN-sGvccYWM5EGCdJob6kgiVMkkyZ0CbslryhLkZIr2gynUoflJ6oxEEW4Jgy-uCnaGDLWkONwHrZgL40gy96cVbghrza1O6catN60tnMzAeqFB_u8YHJSvg5DP0LEAyPgFoKrBNuFtugTVc4Muob3_TXPzsyqlzsCk4m7-4wW97ie6OQ-MV2r_8tXGv0V5rNwfdW_gb-7eJ0Q
link.rule.ids 230,315,782,786,887,27933,27934
linkProvider Multiple Vendors
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Epilepsy+surgery+trends+in+the+United+States%2C+1990-2008&rft.jtitle=Neurology&rft.au=Englot%2C+D+J&rft.au=Ouyang%2C+D&rft.au=Garcia%2C+P+A&rft.au=Barbaro%2C+N+M&rft.date=2012-04-17&rft.eissn=1526-632X&rft.volume=78&rft.issue=16&rft.spage=1200&rft.epage=1206&rft_id=info:doi/10.1212%2FWNL.0b013e318250d7ea&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0028-3878&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0028-3878&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0028-3878&client=summon